{"nct_id":"NCT01336621","title":"Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)","status":"COMPLETED","status_verified_date":"2020-03","start_date":"2011-02-21","start_date_type":"ACTUAL","primary_completion_date":"2016-12-14","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}